Fox Chase Cancer Center’s Dr. Andrea Porpiglia Inducted Into Philadelphia Academy of Surgery

PHILADELPHIA (October 21, 2022)—Fox Chase Cancer Center’s Andrea Porpiglia, MD, MSc, FACS, assistant professor in the Department of Surgical Oncology, was recently inducted as a fellow into the Philadelphia Academy of Surgery.

Founded in 1879, the academy is the oldest continuously meeting surgical society in the United States. Its aim is to improve the practice of surgery, promote public health, and to help elevate the medical profession.

“It is an honor to be inducted into this prestigious academy, which is one of the oldest surgical societies. The academy has a long history of members who are leaders in Philadelphia and it is a privilege to be a part of this historic group,” said Porpiglia.

“Dr. Porpiglia’s induction into this distinguished academy is a testament to the dedication and care she shows her patients every day,” said Jeffrey Farma, MD, FACS, chief of the Division of General Surgery at Fox Chase. “The Philadelphia Academy of Surgery serves as a longstanding hub for some of the best minds in surgery. With Dr. Porpiglia’s induction, Fox Chase will be well represented among those individuals.”

In order to become a fellow of the academy, a candidate must be a medical doctor or doctor of osteopathy who has graduated from a reputable school of medicine or osteopathy. They must also be either board certified in a surgical specialty by an American board of medical specialties or a fellow of the American College of Surgeons. Additionally, they must be nominated by an existing fellow in good standing and supported by another fellow before receiving approval from the council and being presented to the academy for election.

After completing her residency at the University of Tennessee Health Science Center in Memphis, Porpiglia trained as a surgical oncology fellow at Fox Chase in 2013. She then worked in private practice in the Philadelphia area for five years. She returned to Fox Chase as an instructor and surgeon in 2020.

Porpiglia’s focus is on soft tissue cancers, including gastrointestinal stromal tumors, sarcomas, breast, melanoma, and skin cancers. Other specialties include neuroendocrine tumors, colorectal, and stomach cancer. She is a member of the American Society of Clinical Oncology, the Association of Women Surgeons, the Pennsylvania Medical Society, and the Society of Surgical Oncology. 


Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427